Italia    
North America
South America
Europe
Middle East / Africa
Asia / Pacific
×
×

Riferimento

  1. WHO. Patient Safety. 2017. Available at: http://www.euro.who.int/en/health-topics/Health-systems/patient-safety/patient-safety. Accessed October 2017.
  2. Frost and Sullivan. Patient safety in healthcare, forecast to 2022. Investment trends, growth opportunities, challenges and future perspectives. September 2017.
  3. NICE. Infection: prevention and control of healthcare-associated infections in primary and community care. Available at: - https://www.nice.org.uk/guidance/cg139/resources/healthcareassociated-infections-prevention-and-control-in-primary-and-community-care-pdf-35109518767045. Accessed October 2017.
  4. European Centre for Disease Prevention and Control. The bacterial challenge: time to react. 2009. Available at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf. Accessed October 2017.
  5. European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. 2011-2012. Available at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf. Accessed October 2017.
  6. Fleischmann C, et al. Fallzahlen und Sterblichkeitsraten von Sepsis-Patienten im Krankenhaus. Deutsches Arzteblatt. 2016;113(10):159-171.
  7. HAI Impact Assessment: Communication from the commission to the european parliament and the council on patient safety, including the prevention and control of healthcareassociated infections and the proposal for a council recommendation on patient safety, including the prevention and control of healthcare associated infections impact assessment. Available at: http://ec.europa.eu/smart-regulation/impact/ia_carried_out/docs/ia_2008/sec_2008_3004_en.pdf. Accessed October 2017.
  8. WHO. Report on the burden of endemic health care-associated infection worldwide. 2011. Available at: http://apps.who.int/iris/bitstream/10665/80135/1/9789241501507_eng.pdf. Accessed October 2017.
  9. Cassini A, et al. Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLOS Medicine. DOI:10.1371. October 2016.
  10. Lamarsalle L, et al. Evaluating the clinical and economic burden of healthcare-associated infections during hospitalization for surgery in France. Epidemiology & Infection. 2013;141(12):2473-2482.
  11. Penel N, et al.. Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis. International Journal of Oral & Maxillofacial Surgery. 2008;37(2):135-139.
  12. Graf K, et al. Economic aspects of deep sternal wound infections. European Journal of Cardio-Thoracic Surgery. 2010;37(4):893.
  13. Gili-Ortiz E, et al. Surgical site infections in patients who undergo radical cystectomy: Excess mortality, stay prolongation and hospital cost overruns. Actas Urologicas Espanolas. 2015;39(4):210-216.
  14. Alfonso JL, et al. Are we really seeing the total costs of surgical site infections? A Spanish study. Wound Repair & Regeneration. 2007;15(4):474-481.
  15. Rello J, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. American Journal of Respiratory & Critical Care Medicine. 2000;162(3 Pt 1):1027-1030.
  16. Schwebel C, et al. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Critical Care Medicine. 2012;40(1):11-17.
  17. Tarricone R, et al. Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers. The case of Intensive Care Units in Italy. Cost Effectiveness & Resource Allocation. 2010;8:8.
  18. Bittner MI, et al. How is intensive care reimbursed? A review of eight European countries. Annals of Intensive Care. 2013;3:37-46.
  19. Taxis K and Barber N. Incidence and severity of intravenous drug errors in a German hospital. Eur J of Clin Pharmacology. 2004;59:815-817.
  20. Bates DW, et al. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10(4):199-205.
  21. von Laue NC, et al. The epidemiology of preventable adverse drug events: a review of the literature. Wien Klin Wochenschr. 2003;115(12):407-415.
  22. Buckley MS, et al. Direct observation approach for detecting medication errors and adverse drug events in a pediatric intensive care unit. Pediatr Crit Care Med. 2007;8(2):145-152.
  23. Cassano-Piche A, et al. Multiple intravenous infusions phase 1b: practice and training scan. Ontario Health Quality. 2012;12(16):1-132.
  24. Valentin A, et al. Errors in administration of parenteral drugs in intensive care units: multinational prospective study. BMJ. 2009;338:b814.
  25. Cousins DH, et al. Medication errors in intravenous drug preparation and administration: a multicentre audit in the UK, Germany and France. Quality & safety in health care. 2005;14(3):190-195.
  26. World Health Organization. Antimicrobial Resistance Fact Sheet. http://www.who.int/mediacentre/factsheets/fs194/en/. Accessed November 28, 2017.
  27. Centers for Disease Control and Prevention. About antimicrobial
    resistance. https://www.cdc.gov/drugresistance/about.html. Accessed May 12, 2017.
  28. Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance, 2016.
  29. World Bank. 2016. http://www.worldbank.org/en/news/press-release/2016/09/18/by-2050-drug-resistant-infections-could-cause-global-economic-damage-on-par-with-2008-financial-crisis. Accessed October 12, 2017.
  30. Centers for Disease Control and Prevention. Basic infection control and prevention plan for outpatient oncology settings. https://www.cdc.gov/hai/pdfs/guidelines/basic-infection-control-prevention-plan-2011.pdf. 2011. Accessed
    July 25, 2017.
  31. Centers for Disease Control and Prevention. Making healthcare safer. https://www.cdc.gov/vitalsigns/protect-patients/index.html. 2016. Accessed July 25, 2017.
  32. Fleming-Dutra KE, Hersh AL, Shapiro DJ,
    et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA. 2016;315(17):1864-1873.
  33. Caliendo AM, Gilbert DN, Ginocchio CC, et al. Better tests, better care: improved
    diagnostics for infectious diseases. Clin Infect Dis. 2013;57(suppl 3):S139-S170.
  34. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. https://www.cdc.gov/drugresistance/
    pdf/ar-threats-2013-508.pdf. Accessed July 11, 2017.
  35. Boyce JM. Modern technologies for improving cleaning and disinfection of environmental surfaces in hospitals. Antimicrob Resist Infect Control. 2016;5:10.
  36. Weinstein RA. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis. 2001;7(2):188-192.
  37. BMJ Best Practice: Sepsis in Adults. Epidemiology. Available from: http://bestpractice.bmj.com/best-practice/monograph/245/basics/epidemiology.html.
  38. Ron Daniels. Surviving the first hours in sepsis: getting the basics right (an intensivist’s perspective). J Antimicrob Chemother. 2011.
  39. Davies A, Green C, Hutton J. Severe sepsis: a European estimate of the burden of disease in ICU. Intensive Care Medicine. 2001;27:S284.
  40. Frontier Health. Exploring the costs of unsafe care in the NHS - A report prepared for the department of health. October 2014. Available from: - https://www.frontier-economics.com/media/2459/exploring-the-costs-of-unsafe-care-in-the-nhs-frontier-report-2-2-2-2.pdf.
  41. Davies A, Green C, Hutton J. Severe sepsis: a European estimate of the burden of disease in ICU. Intensive Care Medicine.2001;27:S284.
  42. Storrow AB, Zhou C, Gaddis G et al. Decreasing lab turnaround time improves emergency department throughput and decreases emergency medical services diversion: a simulation model. Academic Emergency Medicine. 2008;15(11):1130-5.
  43. https://www.oecd.org/els/health-systems/The-economics-of-patient-safety-March-2017.pdf
  44. EMA/787897/2015 http://www.ema.europa.eu/docs/en_GB/document_library/Other/2015/11/WC500197135.pdf
  45. https://ww2.frost.com/event/calendar/2017-london-awards/
  46. Policy Research Unit in Economic Evaluation of Health & Care Interventions (EEPRU) prevalence and economic burden of medication errors in the NHS in England. University of Sheffield February 2018
  47. Quenot J, Pavin A, Fournel I et al. Le choc septique de l’adulte en France : vingt ans de données épidémiologiques. Réanimation (2015) 24:303-309
  48. Brun-Buisson Mise au point - Épidémiologie des états septiques graves - 01/03/08 Doi : PM-03-2006-35-3-C2-0755-4982-101019-200601889. Available from http://www.em-consulte.com/article/102977/mise-au-point-epidemiologie-des-etats-septiques-gr
  49. http://www.amcli.it/wp-content/uploads/2015/10/Sepsi-30settembre2017.pdf
  50. https://www.lastampa.it/2018/09/13/scienza/sepsi-secondo-loms-entro-il-causer-pi-morti-delle-patologie-oncologiche-ACOSkWGgqe7jhv6c882u1O/pagina.html
  51. https://www.lettera43.it/it/articoli/cronaca/2017/05/02/sanita-incidenza-e-costi-delle-infezioni-ospedaliere/210257/
  52. https://www.lastampa.it/2018/09/13/scienza/sepsi-secondo-loms-entro-il-causer-pi-morti-delle-patologie-oncologiche-ACOSkWGgqe7jhv6c882u1O/pagina.html

Torna alla sicurezza del paziente

Riferimento

Azienda
Assistenza